Nothing Special   »   [go: up one dir, main page]

Wang et al., 2010 - Google Patents

Calcium carbonate/carboxymethyl chitosan hybrid microspheres and nanospheres for drug delivery

Wang et al., 2010

Document ID
16750936468140612395
Author
Wang J
Chen J
Zong J
Zhao D
Li F
Zhuo R
Cheng S
Publication year
Publication venue
The Journal of Physical Chemistry C

External Links

Snippet

Calcium carbonate/carboxymethyl chitosan (CaCO3/CMC) hybrid microspheres and nanospheres were prepared by the precipitation of calcium carbonate in an aqueous solution containing CMC. Through adjusting the preparation conditions, the size of …
Continue reading at pubs.acs.org (other versions)

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48769Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
    • A61K47/48853Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/30Macromolecular compounds

Similar Documents

Publication Publication Date Title
Wang et al. Calcium carbonate/carboxymethyl chitosan hybrid microspheres and nanospheres for drug delivery
Bayer Hyaluronic acid and controlled release: A review
Liang et al. Cosynthesis of cargo-loaded hydroxyapatite/alginate core–shell nanoparticles (HAP@ Alg) as pH-responsive nanovehicles by a pre-gel method
Bodnar et al. Preparation and characterization of chitosan-based nanoparticles
Qin et al. Self-assembly of metal–phenolic networks as functional coatings for preparation of antioxidant, antimicrobial, and pH-sensitive-modified starch nanoparticles
Yang et al. Preparation and application of micro/nanoparticles based on natural polysaccharides
Gadziński et al. Ionotropic gelation and chemical crosslinking as methods for fabrication of modified-release gellan gum-based drug delivery systems
Shenoy et al. Layer-by-layer engineering of biocompatible, decomposable core− shell structures
Xiao et al. Direct formation of silk nanoparticles for drug delivery
Zhao et al. Polyethylenimine-grafted cellulose nanofibril aerogels as versatile vehicles for drug delivery
Narayanan et al. Versatile carboxymethyl chitin and chitosan nanomaterials: a review
Fan et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique
Simovic et al. Silica materials in drug delivery applications
Wang et al. Colloidal stability of silk fibroin nanoparticles coated with cationic polymer for effective drug delivery
Marie et al. Synthesis of chitosan-stabilized polymer dispersions, capsules, and chitosan grafting products via miniemulsion
Massaro et al. Multifunctional carrier based on halloysite/laponite hybrid hydrogel for kartogenin delivery
Liu et al. Preparation and characterization of nanoparticles containing trypsin based on hydrophobically modified chitosan
Peng et al. Preparation of hierarchical mesoporous CaCO 3 by a facile binary solvent approach as anticancer drug carrier for etoposide
Schwall et al. Micro-and nanoscale hydrogel systems for drug delivery and tissue engineering
Yan et al. Stable and biocompatible cellulose-based CaCO3 microspheres for tunable pH-responsive drug delivery
Ebara Biomaterials nanoarchitectonics
Wang et al. Enhanced resistance of polyelectrolyte multilayer microcapsules to pepsin erosion and release properties of encapsulated indomethacin
Maeda et al. Pickering-type water-in-oil-in-water multiple emulsions toward multihollow nanocomposite microspheres
Pan et al. A hierarchical porous bowl-like PLA@ MSNs-COOH composite for pH-dominated long-term controlled release of doxorubicin and integrated nanoparticle for potential second treatment
Zhang et al. Fabrication and characterization of quercetagetin-loaded nanoparticles based on shellac and quaternized chitosan: Improvement of encapsulation efficiency and acid and storage stabilities